NZ334086A - A process for preparing plurality of homeopathic compositions - Google Patents
A process for preparing plurality of homeopathic compositionsInfo
- Publication number
- NZ334086A NZ334086A NZ334086A NZ33408697A NZ334086A NZ 334086 A NZ334086 A NZ 334086A NZ 334086 A NZ334086 A NZ 334086A NZ 33408697 A NZ33408697 A NZ 33408697A NZ 334086 A NZ334086 A NZ 334086A
- Authority
- NZ
- New Zealand
- Prior art keywords
- beta
- radiation
- homeopathic
- solution
- energy range
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
A process that is preferably able to be used in an industrial scale for preparing homeopathic medicinal composition which comprises: (a) providing an initial solution containing a predetermined starting concentration of a selected compound having homeopathic efficacy; (b) diluting the initial solution using at least one dilution step by addition of diluent so as to produce following the or each dilution step a diluted preparation having a lower concentration of the selected compound than the concentration of the selected compound in the solution being diluted; and (c) packaging the resulting homeopathic medicinal preparation in a container adapted to protect the homeopathic medicinal composition from 'beta'- radiation, including emitted 'beta'- radiation in the tritium energy range, until required for consumption by a patient; wherein the dilution, succussion and packaging steps are carried out within an environment shielded from 'beta'- radiation, including emitted 'beta'- radiation in the tritium energy range. Also provided is a package comprising a storage container which is adapted to shield its contents from the effects of 'beta'- radiation, including emitted 'beta'- radiation in the tritium energy range, containing a charge of a homeopathic medicinal preparation which has been prepared by the process of the invention. The homeopathic medicinal preparation can be in the form of granules or globules containing, for example, from about 0.005 g to about 0.05 g of an inert solid carrier material, such as lactose, or can be in tablet, ointment or paste form. Concentrations as low as 10-60 molar solution (30 CH solution) appeared to be effective in homeopathic treatment.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9616728.3A GB9616728D0 (en) | 1996-08-09 | 1996-08-09 | Process, product and package |
PCT/GB1997/002124 WO1998006383A1 (en) | 1996-08-09 | 1997-08-05 | Homeopathic composition and process for its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ334086A true NZ334086A (en) | 2000-05-26 |
Family
ID=10798244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ334086A NZ334086A (en) | 1996-08-09 | 1997-08-05 | A process for preparing plurality of homeopathic compositions |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0918512A1 (en) |
JP (1) | JP2000516605A (en) |
AU (1) | AU714261B2 (en) |
BR (1) | BR9711051A (en) |
CA (1) | CA2263097A1 (en) |
GB (1) | GB9616728D0 (en) |
NZ (1) | NZ334086A (en) |
WO (1) | WO1998006383A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH692476A5 (en) * | 1998-03-18 | 2002-07-15 | Gerhard Moser | A process for the production of homeopathic medicines. |
FR2793657B1 (en) * | 1999-05-19 | 2001-08-24 | Sante Nutrition Selection Diff | PROCESS FOR MANUFACTURING PRODUCTS USED FOR MICRONUTRITION |
WO2003019316A1 (en) * | 2001-08-22 | 2003-03-06 | Reyes Arellano J Cristobal | Homeopathic stimulant composition for seed production |
FR2883654B1 (en) * | 2005-03-25 | 2007-05-11 | Jean Francois Comet | CONTROL METHOD FOR THE ARTISAN MANUFACTURE OF HOMEOPATHIC REMEDIES CONFORMING TO THE PRINCIPLES OF THE FOUNDER OF HOMEOPATHY |
WO2015104523A1 (en) * | 2014-01-07 | 2015-07-16 | Mitchell Deborah | Methods involving skin cosmetics |
CN113347995A (en) * | 2018-12-28 | 2021-09-03 | 卢遂显 | Preparation method of solid water particles for homeopathy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2617463B2 (en) * | 1987-07-03 | 1989-12-08 | Dolisos Labo Pharmaco Homeopat | CAP FOR CLOSING TUBES AND VIALS, PARTICULARLY FOR PHARMACEUTICAL PRODUCTS |
CH670766A5 (en) * | 1986-04-12 | 1989-07-14 | Helmut Dr Dr Med Fichter | Earth radiation elimination device for homeopathic treatment - has respective coils contained in successive compartments along length of wooden housing |
GB9007945D0 (en) * | 1990-04-07 | 1990-06-06 | Beecham Group Plc | Pharmaceutical formulation |
DE4201179A1 (en) * | 1992-01-17 | 1993-07-22 | Alfatec Pharma Gmbh | Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc. |
-
1996
- 1996-08-09 GB GBGB9616728.3A patent/GB9616728D0/en active Pending
-
1997
- 1997-08-05 EP EP97933810A patent/EP0918512A1/en not_active Withdrawn
- 1997-08-05 CA CA002263097A patent/CA2263097A1/en not_active Abandoned
- 1997-08-05 NZ NZ334086A patent/NZ334086A/en unknown
- 1997-08-05 BR BR9711051-5A patent/BR9711051A/en not_active IP Right Cessation
- 1997-08-05 AU AU37046/97A patent/AU714261B2/en not_active Ceased
- 1997-08-05 WO PCT/GB1997/002124 patent/WO1998006383A1/en not_active Application Discontinuation
- 1997-08-05 JP JP10509484A patent/JP2000516605A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB9616728D0 (en) | 1996-09-25 |
AU714261B2 (en) | 1999-12-23 |
EP0918512A1 (en) | 1999-06-02 |
AU3704697A (en) | 1998-03-06 |
JP2000516605A (en) | 2000-12-12 |
WO1998006383A1 (en) | 1998-02-19 |
CA2263097A1 (en) | 1998-02-19 |
BR9711051A (en) | 2000-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA921804B (en) | Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them. | |
ES8400870A1 (en) | Process for preparing solid shaped articles. | |
YU48666B (en) | Mometason monohydrate furoate and method of preparation thereof | |
HU179793B (en) | Process for preparing 4-amino-5-sulphonyl-o-anisamide derivatives and pharmaceutical preparations containing such compounds as active materials | |
PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
ES486279A1 (en) | Hydroxypropyl triazoles, process for their preparation and medicaments containing these compounds. | |
ZA917701B (en) | Heterocycle-substituted alkylamines,process for preparing these and pharmaceutical compositions containing them | |
NZ334086A (en) | A process for preparing plurality of homeopathic compositions | |
IL57452A (en) | Method and compositions containing cycloalkanecarboxylic acid derivatives for regulating plant growth,certain such novel compounds and their preparation | |
IL60614A0 (en) | Method and compositions containing heterocyclic compounds for combating fungus and/or regulating plant growth,certain novel heterocyclic compounds and their preparation | |
RU93046714A (en) | MEPIKVATKHLORID, METHOD OF OBTAINING, PREPARATIVE FORM AND METHOD OF CULTIVATION OF COTTON | |
US5314678A (en) | Sodium iodide 131 I capsules | |
HUT34318A (en) | Process for preparing 3-phenyl-4-cyano-pyrrole derivatives further microbicide compositions containing such compounds as active substances | |
FI935019A (en) | Process for the preparation of a clodronate preparation | |
EP0061268B1 (en) | Stabilised peroxide composition and method of producing the same | |
IL102949A (en) | Substituted mandelic acid derivatives their preparation and pharmaceutical compositions containing them | |
JPS6145961B2 (en) | ||
EP0168245A3 (en) | Pharmaceutical compositions of antianginal activity | |
ES483087A1 (en) | 5(6)-(2-Amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them. | |
ES8302634A1 (en) | Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions. | |
HUT41022A (en) | Process for preparing 2-halogen-6-methyl-ergol-9-ene derivatives and acid additional salts thereof | |
ES8206544A1 (en) | 4-carbamoyloxy-oxazaphosphorine compound | |
DE2966607D1 (en) | Medicines containing as active ingredients compounds of the benzene-sulfone type; compounds of this type and process for their preparation | |
US3357131A (en) | Method for protecting plants in a salt-containing environment | |
HUT34020A (en) | Process for preparing new cyano-guanidine derivatives and pharmaceutical compositions containing such derivatives as active substances |